Related Experiment Video

Updated: Jun 13, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

Targeting DNA repair in breast cancer: a clinical and translational update

Eitan Amir1, Bostjan Seruga, Rosario Serrano

  • 1Medical Oncology Department, Princess Margaret Hospital, 610 University Avenue, Toronto, Canada.

Cancer Treatment Reviews
|April 14, 2010
PubMed

Insights

DNA repair is crucial for preventing cancer. Inhibiting Poly (ADP-ribose) polymerase (PARP) offers a promising therapeutic strategy for breast tumors with DNA repair deficiencies, particularly those with BRCA1/BRCA2 mutations.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • DNA repair mechanisms are vital for genomic stability and cancer prevention.
  • Defects in DNA repair pathways, such as those involving BRCA1 and BRCA2, are implicated in breast cancer development.
  • Targeting complementary DNA repair pathways presents a potential therapeutic strategy for cancer treatment.

Purpose of the Study:

  • To review the clinical and biological data supporting the development of DNA repair-targeting drugs.
  • To focus on the application of Poly (ADP-ribose) polymerase (PARP) inhibitors in breast cancer treatment.
  • To explore the potential of PARP inhibition in both hereditary and sporadic breast cancers with DNA repair deficiencies.

Main Methods:

  • Literature review of clinical and biological data.
  • Analysis of the role of Poly (ADP-ribose) polymerase (PARP) in DNA repair.
  • Examination of synthetic lethality principles in cancer therapy.

Main Results:

  • Poly (ADP-ribose) polymerase (PARP) inhibitors demonstrate synthetic lethality in tumors with homologous recombination deficiency.
  • Clinical development of PARP inhibitors is advancing for breast cancer patients, especially those with BRCA1/BRCA2 mutations.
  • Sporadic breast cancers, particularly basal-like types, may also benefit from PARP inhibition due to DNA repair defects.

Conclusions:

  • PARP inhibitors represent a targeted therapy for breast cancers with specific DNA repair deficiencies.
  • The therapeutic potential extends to a broader population of breast cancer patients beyond those with germline BRCA mutations.
  • Further research into DNA repair pathways and targeted inhibition holds promise for novel breast cancer treatments.

More Related Videos

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

Visualization of DNA Repair Proteins Interaction by Immunofluorescence07:55

Visualization of DNA Repair Proteins Interaction by Immunofluorescence

Published on: June 26, 2020

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Overview of DNA Repair02:25

Overview of DNA Repair

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
Overview of DNA Repair02:25

Overview of DNA Repair

In order to be passed through generations, genomic DNA must be undamaged and error-free. However, every day, DNA in a cell undergoes several thousand to a million damaging events by natural causes and external factors. Ionizing radiation such as UV rays, free radicals produced during cellular respiration, and hydrolytic damage from metabolic reactions can alter the structure of DNA. Damages caused include single-base alteration, base dimerization, chain breaks, and cross-linkage.
Chemically...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...